Effect of streptozotocin-induced diabetes on oxidative energy metabolism in rat kidney mitochondria. A comparative study of early and late effects

Diabetes, Obesity and Metabolism

Volumn 7, Issue 5, 2005, Pages 555-562

  Katyare, Surendra S ^a   Satav, J G ^b,c  

^a M S UNIVERSITY OF BARODA   (India)

^b BHABHA ATOMIC RESEARCH CENTRE   (India)

^c NONE   (India)

Author keywords

Cytochrome content; Diabetes and mitochondrial ATPase; Energy metabolism; Kidney mitochondria; STZ diabetes

Indexed keywords

3 HYDROXYBUTYRATE DEHYDROGENASE; 3 HYDROXYBUTYRIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASE; ASCORBIC ACID; CYTOCHROME; GLUTAMIC ACID; ISOPHANE INSULIN; MALIC ACID; N,N,N',N' TETRAMETHYL 1,4 PHENYLENEDIAMINE; OXYGEN; PYRUVIC ACID; STREPTOZOCIN; SUCCINATE DEHYDROGENASE; SUCCINIC ACID;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREATHING RATE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME SUBSTRATE; EXPERIMENTAL ANIMAL; INTERMETHOD COMPARISON; KIDNEY PARENCHYMA; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; PROTEIN ANALYSIS; RAT; STREPTOZOCIN DIABETES;

EID: 23844543432     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2004.00429.x     Document Type: Article

References (41)

1. Alberti KGMM, Press CM. The biochemistry of the complications of diabetes mellitus. In: Keen M, Jarrett J, eds. Complications of Diabetes. London: Edward Arnold Ltd, 1982; 231-270.
2. Striker GE, Peten EP, Carome MA et al. The kidney disease of diabetes mellitus (KDDM). A cell and molecular biology approach. Diabetes Metab Rev 1993; 9: 37-56.
3. Osterby R. Glomerular structural changes in diabetes mellitus. In: Mognsen CE, ed. The Kidney and Hypertension in Diabetes Mellitus. Boston: Martinus-Nijhoff Publishing, 1988; 99-105.
4. Cohen MP. Nonenzymatic glycation and enhanced polyol pathway activity in pathogenesis of diabetic nephropathy. In: Reidland A, Koch KM, Heidbreder E, eds. Diabetes and the Kidney, Contrib Nephrology, Vol. 73. Basel: Karger, 1989; 59-72.
5. Petersen J, Ross J, Rabkin R. Effect of insulin treatment on established diabetic nephropathy in rats. Diabetes 1988; 37: 1346-1350.
6. Obineche EN, Mensah-Brown E, Chandranath SI, Ahmed I, Nasser O, Adem A. Morphological changes in the rat kidney following long-term diabetes. Arch Physiol Biochem 2001; 109: 241-245.
7. + ATPase activity after insulin treatment in streptozotocin-diabetic rats. Endocrinology 1987; 129: 2166-2173.
8. Ball MR, McLean P. Differential response of liver and kidney adenine nucleotide translocase and pyruvate dehydrogenase activity to alloxan diabetes. Enzyme 1983; 29: 15-20.
9. + ATPase activity in kidney, brain and erythrocyte membranes in alloxan-diabetic rats. Ind J Exp Biol 1992; 30: 26-32.
10. Nobrega MA, Fleming S, Roman RJ et al. Initial characterization of a rat model of diabetic nephropathy. Diabetes 2004; 53: 735-742.
11. Coimbra TM, Janssen U, Grone HJ et al. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 2000; 57: 167-182.
12. + ATPase: its role in sodium and potassium transport. Am J Physiol 1982; 242: F207-F219.
13. Park C, Drake RL. Insulin mediates the stimulation of pyruvate kinase by a dual mechanism. Biochem J 1982; 208: 333-337.
14. Bessman SP, Mohan C. Insulin as a probe of mitochondrial metabolism in situ. Mol Cell Biochem 1997; 174: 91-96.
15. Gerbitz K-D, Gempel K, Brdiczka D. Mitochondria and Diabetes: Genetic, biochemical, and clinical implications of the cellular energy circuit. Diabetes 1996; 45: 113-126.
16. Berdanier CD. Diabetes and Nutrition. The mitochondrial part. J Nutr 2001; 131: S344-S353.
17. Everts HB, Classen DO, Hermoiyan CR, Berdanier CD. Nutrient-gene interactions: vitamin A and mitochondrial gene expression. IUBMB Life 2002; 53: 295-301.
18. Brignone JA, Campos de Brignone CM, Rodriguez RR, Badano BN, Stoppani AOM. Modified oscillation behavior and decreased D-3-hyroxybutyrate dehydrogenase activity in diabetic rat liver mitochondria. Arch Biochem Biophys 1982; 214: 581-588.
19. Satav JG, Katyare SS. Effect of streptozotocin-induced diabetes on oxidative energy metabolism in rat liver mitochondria. A compatative study of early and late effects. Ind J Clin Biochem 2004; 19: 23-31.
20. Reinhart RW, Roberson J, Beattie D. The effect of diabetes on protein synthesis and the respiratory chain of rat skeletal muscle and kidney mitochondria. Arch Biochem Biophys 1987; 213: 341-352.
21. Katyare SS, Balasubramanian S, Parmar DV. Effect of corticosterone treatment on mitochondrial oxidative energy metabolism in developing rat brain. Exp Neurol 2003; 183: 241-248.
22. Katewa SD, Katyare SS. Treatment with antimalarials adversely affects the oxidative energy metabolism in rat liver mitochondria. Drug Chem Toxicol 2004; 27: 43-55.
23. Nerurkar MA, Satav JG, Katyare SS. Insulin-dependant changes in lysosomal cathepsin D activity in rat liver, kidney, brain and heart. Diabetologia 1988; 31: 119-122.
24. Satav JG, Katyare SS. Effect of thyroidectomy and subsequent treatment with triiodothyronine on kidney mitochondrial oxidative phosphorylation in the rat. J Biosci 1991; 16: 81-89.
25. Katyare SS, Satav JG. Impaired mitochondrial oxidative energy metabolism following paracetamol-induced hepatotoxicity in the rat. Br J Pharmacol 1989; 96: 51-58.
26. Swegert CV, Dave KR, Katyare SS. Effect of aluminium-induced Alzheimer like condition on energy metabolism of rat liver, brain and heart mitochondria. Mech Ageing Dev 1999; 117: 27-42.
27. Shukla VH, Dave KR, Katyare SS. Effect of catecholamine depletion on oxidative energy metabolism in rat liver, brain and heart mitochondria; use of reserpine. Comp Biochem Physiol 2000; 127: 79-90.
28. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
29. Bedetti CD, Montero GA, Stoppani AOM. Effect of diabetes, adrenelalectomy and hypophysectomy on D-3-hyroxybutyrate dehydrogenase activity and substrate oxidation by rat mitochondria. Biochem Int 1987; 14: 45-54.
30. Daum G. Lipids of mitochondria. Biochim Biophys Acta 1985; 822: 1-42.
31. Ido Y, Vindigni A, Chang K et al. Prevention of vascular and neuronal dysfunction in diabetic rat by C-peptide. Science 1997; 277: 563-566.
32. Steiner DE, Rubenstein AM. Proinsulin C-peptide - Biological activity? Science 1997; 277: 531-532.
33. Oppenheimer JH. Thyroid hormone action at the cellular level. Science 1980; 202: 971-979.
34. Raza H, Prabu SK, Robin MA, Avadhani NG. Enhanced mitochondrial cytochrome P450 2E1 and glutathione-S-transferase A4-4 in streptozotocin-induced diabetic rats: tissue-specific variations and roles in oxidative stress. Diabetes 2004; 53: 185-194.
35. Bastar I, Seckin S, Uysal M, Aykac-Toker G. Effect of streptozotocin on glutathione and lipid peroxide levels in vatious tissues of rats. Res Commun Mol Pathol Pharmacol 1998; 102: 265-272.
36. Liu S, Barak-Nieto M. Renal protein degradation in streptozotocin diabetic mice. Diabetes Res Clin Pract 1997; 34: 143-148.
37. Jang YY, Song JH, Shin YK, Han ES, Lee CS. Protective effect of boldine on oxidative mitochondrial damage in streptozotocin-induced diabetic rats. Pharmacol Res 2000; 42: 361-371.
38. Satav JG, Dave KR, Katyare SS. Influence of insulin status on extra-mitochondrial oxygen metabolism in the rat. Horm Metab Res 2000; 32: 57-61.
39. Oberley LW. Free radicals and diabetes. Free Radic Biol Med 1988; 5: 113-124.
40. Kehrer JP. Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol 1993; 23: 21-48.
41. Boquist L, Nelson L, Lorentson R. Uptake of labeled alloxan in mouse organs and mitochondria in vivo and in vitro. Endocrinol 1983; 113: 943-948.